Home » Thought Leadership » Infographics » China’s 2020 NRDL –…

China’s 2020 NRDL – Standout Features from the Finalized List

January 27, 2021


Written by: Wenting Zhang, PhD Annabelle Brough

162 drugs underwent negotiations, resulting in a negotiation success rate of 73% (119 drugs) and an average price discount of 51%. PD-1 products again took center stage this year, with all domestic Chinese-manufactured PD-1 products successfully negotiated and listed on the NRDL. The updated NRDL will take effect from March 01, 2021.

In this infographic, CBPartners evaluates the standout features and and lists the key takeaways of the 2020 NRDL update.

Read the infographic here.


If you are interested in reading more about the Asia-Pacific landscape, read related posts in the Center of Excellence team’s thought leadership channel, or find out more about the work we do.